Skip to main content

ORIGINAL RESEARCH article

Front. Pharmacol.
Sec. Integrative and Regenerative Pharmacology
Volume 15 - 2024 | doi: 10.3389/fphar.2024.1476820

Protective Effects of Small RNAs Encapsulated in Artemisia Capillaris-Derived Exosomes Against Nonalcoholic Fatty Liver Disease

Provisionally accepted
Min Xu Min Xu 1Longjun Ma Longjun Ma 2*Hongwei Liang Hongwei Liang 3*Wei Tang Wei Tang 4*Shouyong Gu Shouyong Gu 5*
  • 1 The Fourth Clinical Medical College of Nanjing Medical University, Nanjing, China
  • 2 Department of Epidemiology, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu Province, China
  • 3 Department of Emergency, Nanjing Drum Tower Hospital, School of Life Science and Technology, China Pharmaceutical University, Nanjing, China, nanjing, China
  • 4 Department of Endocrinology,Geriatric Hospital of Nanjing Medical University, Nanjing, China., nanjing, China
  • 5 Institute of Geriatric Medicine, Jiangsu Province Geriatric Hospital, nanjing, China

The final, formatted version of the article will be published soon.

    Introduction: Artemisia capillaris, a traditional medicinal plant, is renowned for its therapeutic properties, including the promotion of anti-inflammatory and bile secretion. Notably, it has demonstrated efficacy in the treatment of jaundice. This study aimed to evaluate the potential of Artemisia capillaris-derived exosomes (ACDEs) as a novel therapeutic approach in nonalcoholic fatty liver disease (NAFLD). Methods: The physicochemical properties of ACDEs were isolated and characterized using differential centrifugation, and the therapeutic efficacy was evaluated in an in vivo methionine choline deficient (MCD) diet induced NAFLD mouse model. In vitro, mouse hepatocytes were treated with palmitic acid (PA) to simulate a high fat environment. Intracellular triglyceride (TG) and total cholesterol (TC) levels were quantified, and Oil Red O staining was assessed.Additionally, the expression levels of proteins and RNAs associated with lipogenesis and inflammation were analyzed. Results: The NAFLD mouse model exhibited notable liver damage, including lipid deposition and inflammatory responses.However, treatment with ACDEs exhibited broad pharmacological activities, effectively reversing hepatic lipid accumulation and inflammatory damage. In vitro experiments revealed that ACDEs were internalized by AML12 cells via macropinocytosis and caveolin-mediated endocytosis. This treatment ameliorated dysregulated lipid metabolism and inhibited inflammatory responses. High throughput sequencing further identified a distinct small RNA profile in ACDEs, indicating the potential involvement in interspecies physiological regulation. Discussion: In conclusion, this study provides evidence for the therapeutic potential of ACDEs in NAFLD and offers a novel perspective for the development of Artemisia capillaris-based therapies for NAFLD, related metabolic disorders, and hepatitis.

    Keywords: Artemisia capillaris, Exosomes, nonalcoholic fatty liver disease, Lipid Metabolism, cross species regulation 1

    Received: 08 Aug 2024; Accepted: 04 Dec 2024.

    Copyright: © 2024 Xu, Ma, Liang, Tang and Gu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence:
    Longjun Ma, Department of Epidemiology, School of Public Health, Nanjing Medical University, Nanjing, 211166, Jiangsu Province, China
    Hongwei Liang, Department of Emergency, Nanjing Drum Tower Hospital, School of Life Science and Technology, China Pharmaceutical University, Nanjing, China, nanjing, China
    Wei Tang, Department of Endocrinology,Geriatric Hospital of Nanjing Medical University, Nanjing, China., nanjing, China
    Shouyong Gu, Institute of Geriatric Medicine, Jiangsu Province Geriatric Hospital, nanjing, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.